Celularity Inc.
CELU
$2.02
$0.000.00%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -43.16% | -52.64% | -22.17% | 49.70% | 145.54% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -43.16% | -52.64% | -22.17% | 49.70% | 145.54% |
| Cost of Revenue | 0.54% | 146.91% | 116.71% | -23.58% | 7.80% |
| Gross Profit | -74.51% | -95.05% | -39.64% | 331.04% | 2,841.85% |
| SG&A Expenses | -26.43% | -20.58% | 1.67% | 22.88% | 17.70% |
| Depreciation & Amortization | -13.33% | -18.42% | -32.60% | -32.01% | -32.19% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -12.92% | -3.08% | -0.66% | 20.24% | 3.67% |
| Operating Income | -11.47% | -55.91% | -42.16% | 12.66% | 29.28% |
| Income Before Tax | -43.35% | -277.99% | 10.26% | -239.09% | 82.85% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -43.35% | -277.99% | 10.26% | -239.24% | 82.85% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -43.35% | -277.99% | 10.26% | -239.24% | 82.85% |
| EBIT | -11.47% | -55.91% | -42.16% | 12.66% | 29.28% |
| EBITDA | -14.98% | -71.54% | -65.75% | 11.15% | 30.98% |
| EPS Basic | -19.56% | -243.89% | 18.23% | -219.86% | 85.31% |
| Normalized Basic EPS | -22.60% | -232.12% | 29.82% | -213.55% | -0.18% |
| EPS Diluted | -19.56% | -243.89% | 18.23% | -219.86% | 85.31% |
| Normalized Diluted EPS | -22.60% | -232.12% | 29.82% | -213.55% | -0.18% |
| Average Basic Shares Outstanding | 19.89% | 9.93% | 9.75% | 16.16% | 16.70% |
| Average Diluted Shares Outstanding | 19.89% | 9.93% | 9.75% | 16.16% | 16.70% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |